Novo Nordisk A/S
OTC: NONOF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Maziar Mike Doustdar
- Employees
- 77,406
- Headquarters
- Bagsvaerd, Denmark
- IPO year
- 2010
- Market cap
- $210.6B
- Website
- https://www.novonordisk.com
Loading NONOF…
Loading profile data…Frequently asked questions about NONOF
What does Novo Nordisk A/S (NONOF) do?
Novo Nordisk A/S operates as a prominent global pharmaceutical firm, dedicated to the discovery, development, production, and distribution of a wide array of medicinal products. Its extensive operations are primarily structured into two distinct divisions: Diabetes and Obesity Care, and Biopharmaceuticals. The Diabetes and Obesity Care segment o...
Where does NONOF trade?
Novo Nordisk A/S (NONOF) trades on the Other OTC.
What sector is NONOF in?
Novo Nordisk A/S (NONOF) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Novo Nordisk A/S?
Maziar Mike Doustdar is the chief executive officer of Novo Nordisk A/S (NONOF).
Where is Novo Nordisk A/S headquartered?
Novo Nordisk A/S is headquartered in Denmark.
Does NONOF pay a dividend?
Yes — Novo Nordisk A/S (NONOF) paid a trailing twelve-month dividend of USD 1.80 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did NONOF go public?
Novo Nordisk A/S (NONOF) completed its initial public offering in 2010.